WASP family member 4, pseudogene (WASF4P)

WASP family member 4, pseudogene (WASF4P) is classified as a pseudogene, meaning it is a DNA sequence that closely resembles a functional gene but is generally considered non-coding and non-functional due to mutation(s) or disruption during evolution[1][2][3]. WASF4P is predicted to bear similarity to members of the WASP family, which regulate actin cytoskeleton dynamics in the cell by interacting with the Arp2/3 complex, but WASF4P itself does not encode a functional protein product and is not known to have a direct biological role or disease association[2][4]. There are currently no known drugs, mechanisms of action, or recognized utility as a therapeutic target. The target name is somewhat problematic because pseudogenes like WASF4P are not considered bona fide drug targets and are generally excluded from therapeutic development pipelines[5]. Key reasons for these assignments: - WASF4P is a **pseudogene**, not a protein-coding gene. It may be transcribed but does not have a known protein product or clear function[1][2]. - It is not considered a drug target, receptor, enzyme, transporter, or similar therapeutic target class[2][3]. - Due to its pseudogene status, there are no associated drugs, mechanisms, or clinical roles, and most biomedical databases categorize it as “other” or omit functional classifications entirely. - The naming (WASP family member 4, pseudogene) includes “pseudogene,” making it clear this is not a canonical functional gene or target. - Aliases like “WASH4P” and “FAM39CP” are reflected in gene databases[2]. - Some recent literature debates possible regulatory or low-level protein-coding activity of some pseudogenes, but there is no evidence that WASF4P is relevant in this way for therapeutic targeting[5].

Other names

WASF4WASH4PFAM39CP